Overview

Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

Status:
Terminated
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
To determine the safety and tolerability of Entinostat in combination with Enzalutamide in metastatic castrate resistant prostate cancer
Phase:
Phase 1
Details
Lead Sponsor:
George Washington University
Treatments:
Entinostat